Document:

ex10_34.htm

Exhibit 10.34

CERTIFICATE OF SUSPENSION OF LOAN COVENANTS

THIS CERTIFICATE OF SUSPENSION OF LOAN COVENANTS is given by RBS CITIZENS, N.A. (d/b/a CHARTER ONE), a national association (“Bank”) to CARACO PHARMACEUTICAL LABORATORIES, LTD., a Michigan corporation (“Borrower”), concerning the enforcement efforts by the Food and Drug Administration, and the voluntary cessation of all manufacturing operations by Borrower.   Bank has issued a notice of the foregoing violations by letter dated July 7, 2009 (the “Notice Letter”).  Borrower acknowledges the receipt of the Notice Letter on July 13, 2009, and acknowledges that the conditions concerning the enforcement efforts by the Food and Drug Administration stated therein are violations of the Loan Agreement between Borrower and Bank dated February 27, 2009, as amended by First Amendment to Loan Agreement dated August 11, 2009, and Second Amendment to Loan Agreement dated October 9, 2009 (collectively, the “Loan Agreement”).

 

Notwithstanding the foregoing, Bank hereby certifies to Borrower that Bank hereby agrees to suspend the required compliance with the covenants in the Loan Agreement pertaining to the violations noted in the Notice Letter until October 9, 2010 and the financial covenants described in Sections 6.7, 6.8 and 6.9 of the Loan Agreement, and forbears from pursuing any and all rights and remedies provided under the terms of the Loan Agreement until such date for those specific violations, at which time Bank reserves the right to review Borrower’s compliance with the covenants of the Loan Agreement hereby suspended, and upon such date all suspension and forbearance of rights and remedies of Bank shall be rescinded and all rights and remedies under the Loan Agreement shall be resumed and enforceable as if this Certificate was never issued.  Nothing herein shall be deemed a waiver of any present conditions that may continue to persist on or after October 9, 2010, nor be deemed to a waiver or suspension of Bank’s rights and remedies with respect to any other current or future violations by Borrower of all covenants in the Loan Agreement.

The effectiveness of this Certificate is contingent on Borrower having executed and delivered to Bank such other documents as deemed necessary by Bank and its counsel to secure Borrower’s Indebtedness (as defined in the Loan Agreement) to Bank with cash collateral, and such cash being deposited with and remaining in possession of Bank while such Indebtedness remains outstanding.

NOW WHEREFORE, the undersigned have executed this Certificate as of February 26, 2010.

	  	
BANK:

	  
	  	
RBS CITIZENS, N.A.

	  
	  	
(d/b/a CHARTER ONE)

	  
	  	  	  	  
	  	
By:

	
/s/ John Sherman

	  
	  	
Name:

	
John Sherman

	  
	  	
Its:

	
Senior Vice President

	  

 

  

  

  

 

	  	
BORROWER:

	  
	  	
CARACO PHARMACEUTICAL

	  
	  	
LABORATORIES, LTD.

	  
	  	  	  	  
	  	
By:

	
/s/ Jitendra Doshi

	  
	  	
Name:

	
Jitendra Doshi

	  
	  	
Its:

	
Chief Executive Officer

	  
	  	  	  	  
	  	
By:

	
/s/ Mukul Rathi

	  
	  	
Name:

	
Mukul Rathi

	  
	  	
Its:

	
Interim Chief Financial Officerex10-18.htm

Exhibit 10.18

Summary of Director Compensation for Fiscal 2009

Each member of the Board of Directors who is not an employee of Tredegar or any of its subsidiaries receives the following annual retainers, payable in equal quarterly installments in arrears:

	
Non-Employee Director

	
$50,000

	
Chairman of the Board

	
$20,000

	
Audit Committee Chairperson

	
$14,000

	
Non-Chair Member of the Audit Committee

	
$  7,500

	
Executive Compensation Committee Chairperson

	
$  9,000

	
Non-Chair Member of the Executive Compensation Committee

	
$  5,000

	
Nominating and Governance Committee Chairperson

	
$  6,000

	
Non-Chair Member of the Nominating and Governance Committee

	
$  3,000

	
Member of the Executive Committee

	
$  4,500

	
Member of the Investment Policy Committee

	
$     625

The retainer paid to non-employee directors is paid $30,000 in cash and $20,000 in the form of a stock award.  The stock award is determined based on the closing price of Tredegar common stock as reported on the New York Stock Exchange composite on the date of grant.ex10_43.htm

    
      

    

    Exhibit
10.43

    
       

      Non-Employee
Director Compensation Summary

       

      As of
December 31, 2009, MCG Capital Corporation’s (the “Company’s”) non-employee
directors were: (i) A. Hugh Ewing, III; (ii) Kim D. Kelly; (iii) Wallace B.
Millner, III; (iv) Richard W. Neu; (v) Kenneth J. O’Keefe; and (vi) Gavin
Saitowitz. The compensation structure for the Company’s non-employee directors
was as follows:

       

      Award
of Restricted Stock Upon Appointment or Election

       

      The SEC
has granted an order authorizing us to award restricted shares of our common
stock to our non-employee directors.  Under the Amended and Restated 2006
Non-Employee Director Restricted Stock Plan, which we refer to as the
2006 Director Plan, non-employee directors each receive an award of 7,500 shares
of restricted stock at the beginning of each three-year term of service on our
board of directors.  Forfeiture provisions lapse as to one-third of
the awarded shares each year over the three-year term.  Awards of
restricted stock under the 2006 Director Plan are automatic and may not be
changed without further approval from the SEC.

       

      Payment
of Retainer Fee; Chair and Committee Fees; Reimbursement of Travel and Other
Expenses

       

      From
January 1, 2009 through July 21, 2009, each non-employee director received an
annual pro-rated retainer of $25,000 for his or her service on our board of
directors.  Additional pro-rated amounts from January 1, 2009 through
July 21, 2009 were paid as follows:

       

      
        	
                Position

              	
                Additional
      Fees

              
	
                Non-Employee
      Chairman of the Board

              	
                $25,000

              
	
                Audit
      Committee Chair

              	
                $25,000

              
	
                Audit
      Committee Members, Compensation Committee Chair and Members, Nominating and
      Corporate Governance Committee Chair and Members, Investment Committee
      Members, Valuation Committee Chair and Members and Enterprise Risk
      Committee Chair and Members

              	
                $25,000/Committee

              

      

       

      From July
22, 2009 through December 31, 2009, each non-employee director received an
annual prorated retainer of $85,000 for his or her service on our board of
directors.  Additional prorated amounts from July 22, 2009 through
December 31, 2009 were paid as follows:

       

      
        	
                Position

              	
                Additional
      Fees

              
	
                Non-Employee
      Chairman of the Board

              	
                $15,000

              
	
                Audit
      Committee and Investment and Valuation Committee Chairs

              	
                $15,000

              
	
                Compensation
      Committee and Nominating and Corporate Governance Committee
      Chairs

              	
                $10,000

              
	
                Audit
      Committee, Compensation Committee, Nominating and Corporate Governance
      Committee and Investment and Valuation Committee Members (in addition to
      fees paid for service as Non-Employee Chairman of the Board and for
      service as Committee chairs)

              	
                $10,000/Committee

              

      

       

      All
retainer amounts were paid quarterly during fiscal 2009 in
arrears.  Non-employee directors also received reimbursement for
reasonable travel and other expenses in connection with attending meetings of
our board of directors during fiscal 2009.Unassociated Document

    
      Exhibit
10.26

    

     

    CapLease,
Inc.

    Summary
of Compensation to

    Independent
Directors

     

    
      	 
      	 	
              
                2010

              

            	 
	
              Annual
      cash
      retainer                                                                      

            	 	$	35,000	 	 	 
	
              Committee
      chair additional
      retainer                                                                      

            	 	$	6,000	(1)	
            	 
	
              Lead
      independent director
      retainer                                                                      

            	 	$	10,000	 	 	 
	
              Stock
      award                                                                      

            	 	$	32,400	(2)	 	 
	Board
      attendance fee (in person or telephonic)	 	$	2,000	 	per
      meeting	 
	Committee
      attendance fee (in person or telephonic)	 	$	1,000	 	per
      meeting	(3) 

    

    
       

      
        
 

    

    (1)Except
for our audit committee chair, who receives $10,000.

     

    (2)Except
for our audit committee chair, who receives $38,700.  The number of
shares granted will be determined by dividing the stock award value by the
average closing price for the Company’s common stock for the 10 trading days
immediately prior to the date the committee makes annual stock
awards.  Awards will be effective on the anniversary of the Company’s
initial public offering and will vest in three equal annual installments
beginning on the first anniversary of such date.

     

    (3)Committee
attendance fees are not paid for meetings held on the same day as a Board
meeting.Unassociated Document

    Promissory
Note

    

    PROMISSORY
NOTE

    

    
      	
              Up
      to $1,200,000

            	
              March
      1,
      2010                         
      

            

    

    

    FOR VALUE RECEIVED, DELTATHREE, INC., a Delaware
corporation, DELTA THREE
ISRAEL, LTD., an Israeli company, and DME SOLUTIONS, INC., a New
York corporation (jointly and severally, the “Borrower”), hereby absolutely,
irrevocably, unconditionally and jointly and severally promises to pay to the
order of D4 HOLDINGS,
LLC, a Delaware limited liability company (“Lender”), in United States
dollars and in immediately available funds, the principal sum of ONE MILLION TWO HUNDRED THOUSAND
DOLLARS ($1,200,000), or such lesser amount as may be advanced by Lender
to the Borrower from time to time in accordance with the terms and conditions of
that certain Loan and Security Agreement dated of even date herewith, between
the Borrower and Lender (as it may be amended, modified, extended or restated
from time to time, the “Loan
Agreement”), together with interest thereon, as provided in the Loan
Agreement.  Notwithstanding the foregoing, the aggregate principal
amount outstanding under this Promissory Note (this “Note”) shall not exceed one
million two hundred thousand dollars ($1,200,000).  This Note is
subject to all of the terms and conditions set forth in, and such terms and
conditions are hereby incorporated herein by reference to, the Loan
Agreement.  All capitalized terms not otherwise defined herein shall
have the meanings set forth in the Loan Agreement.  In the event of
any conflict between the provisions of this Note and the Loan Agreement, the
provisions of the Loan Agreement shall prevail.

    

    The obligations of the Borrower
evidenced by this Note are secured by a first priority perfected security
interest in the Collateral, as set forth in the Loan Agreement.

    

    Except as otherwise provided in the
Loan Documents, all outstanding principal and interest with respect to Loan
Advances shall be due and payable in full on the Maturity Date.  The
daily unpaid principal balance outstanding under this Note shall bear interest
at the rate(s) set forth in the Loan Agreement.

    

    Upon the occurrence of an Event of
Default, Lender shall have, and shall be entitled to exercise, all of the rights
and remedies set forth in the Loan Agreement and the other Loan
Documents.

    

    All payments in respect of amounts
outstanding under this Note shall be paid in immediately available funds to the
account(s) specified by Lender from time to time.  Any payment due in
respect of this Note which falls due on a day other than a Business Day shall be
made on the next Business Day.

    

    The Borrower hereby waives presentment
and demand for payment, notice of dishonor, protest and notice of protest of
this Note.  No release of any security for the payment of this Note or
extension of time for payment of this Note, and no alteration, amendment or
waiver of any provision of this Note made by agreement between Lender and any
other Person shall release, discharge, modify, change or affect the liability of
the Borrower under this Note.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    Each right, power and remedy of Lender
under this Note, the Loan Agreement, any other Loan Document, or under
applicable laws shall be cumulative and concurrent, and the exercise of any one
or more of them shall not preclude the simultaneous or later exercise by Lender
of any or all such other rights, powers or remedies.  No failure or
delay by Lender to insist upon the strict performance of any one or more
provisions of this Note, the Loan Agreement, any other Loan Document, or to
exercise any right, power or remedy consequent upon an Event of Default shall
constitute a waiver thereof, or preclude Lender from exercising any such right,
power or remedy.  No modification, change, waiver or amendment of this
Note shall be deemed to be made unless in writing signed by the Borrower and
Lender. This Note shall inure to the benefit of and be binding upon the Borrower
and Lender and their respective successors and assigns; provided that except as
set forth in the Loan Agreement, the Borrower shall have no right to assign any
of its rights or delegate any of its obligations under this Note; and provided
further that there shall be no restrictions of any nature on Lender’s right to
assign this Note or its rights hereunder.  The invalidity, illegality
or unenforceability of any provision of this Note shall not affect or impair the
validity, legality or enforceability of any other provision.  This
Note shall be deemed to be made in, and shall be governed by the laws of, the
State of Delaware (without regard to its conflicts of laws
principles).

    

    [signature
page follows]

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    IN WITNESS WHEREOF, this Promissory
Note has been duly executed by the undersigned as of the day and year first
above written.

    

    
      
        	 
      	
                BORROWER:

              
	 
      	 
      
	 
      	
                DELTATHREE,
      INC.

              
	 
      	 
      
	 
      	
                By:

              	
                /s/ Effi Baruch

              
	 
      	
                Name:
      Effi Baruch

              
	 
      	
                Title:
      Interim CEO and President

              
	 
      	 
      
	 
      	
                DELTA
      THREE ISRAEL, LTD.

              
	 
      	 
      
	 
      	
                By:

              	
                /s/ Effi Baruch

              
	 
      	
                Name:
      Effi Baruch

              
	 
      	
                Title:
      Interim CEO and President

              
	 
      	 
      
	 
      	
                DME
      SOLUTIONS, INC.

              
	 
      	 
      
	 
      	
                By:

              	
                /s/ Effi Baruch

              
	 
      	
                Name:
      Effi Baruch

              
	 
      	
                Title:
      CEO and President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}]]